We aimed to study the impact of EMT-related markers on a breast cancer cohort and specifically analyze the involvement of Snail, Twist, ZEB1, N-cadherin, Vimentin, GRHL2, E-cadherin, and EpCAM and their respective outcome on both immune infiltration of the TME and clinicopathological features. This evidence concerns the gene CDH1 and breast carcinoma.